Castle Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.01 billion, with shareholders equity totaling $478.44 million.
The company employs approximately 201 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Castle Biosciences Inc. reported $377.13 million in revenue, generating net income of $-23.01 million.
Key financial metrics include a P/E ratio of -44.07, a price-to-book (P/B) ratio of 2.12, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CSTL.